Held on 05 May 2017
Fredun Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 05 May 2017 has approved the following -Increase the authorised capital of the Company by Rs 4 crore to Rs 10 crore.
The Board decided subject to consent of shareholders to issue equity shares under the preferential allotment to preferential shareholders as consideration for redemption of preference shares and also other investors.
To convert Promoters loan to equity.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)